Northwire Canada EditionTuesday, August 25, 2026
Northwire
GOLD 4697.80 +0.4% SILVER 68.59 −1.4% COPPER 6.61 +0.3% OIL 85.01 −2.4% PALLADIUM 1359.75 +0.7% NVO 0.070 +0.0% SRA 0.780 +0.0% TUK 0.020 −20.0% GWM 0.610 −4.7% MINE 0.110 +0.0% EGM 0.100 +0.0% IRO 1.11 +2.8% CBR 1.41 +2.5% CTN 0.045 +0.0% GMX 2.06 +2.0% NPR 0.700 −2.8% CGD 1.28 +8.5% CRE 0.390 +13.0% PE 0.250 +0.0% PER 0.150 +7.1% SVRS 0.540 +8.0% GOLD 4697.80 +0.4% SILVER 68.59 −1.4% COPPER 6.61 +0.3% OIL 85.01 −2.4% PALLADIUM 1359.75 +0.7% NVO 0.070 +0.0% SRA 0.780 +0.0% TUK 0.020 −20.0% GWM 0.610 −4.7% MINE 0.110 +0.0% EGM 0.100 +0.0% IRO 1.11 +2.8% CBR 1.41 +2.5% CTN 0.045 +0.0% GMX 2.06 +2.0% NPR 0.700 −2.8% CGD 1.28 +8.5% CRE 0.390 +13.0% PE 0.250 +0.0% PER 0.150 +7.1% SVRS 0.540 +8.0%
Financings

Cheelcare Closes $1.0 Million Unsecured Note Financing

CHER · Price

Executive Summary

  • Cheelcare Inc. closed its previously‑announced offering of 12% unsecured promissory notes, raising $1,000,000 in gross proceeds.
  • The notes were purchased by Pathfinder Asset Management Ltd. ($750,000) and NameSilo Technologies Corp. ($250,000); they bear simple interest at 12% per annum, payable semi‑annually, with principal due August 11 2027.
  • As part of the transaction, Cheelcare issued 132,450 bonus common shares (valued at 20% of the note principal) subject to a four‑month hold period; proceeds will be used for working capital, inventory, product manufacturing and general corporate purposes.

Key Details

  • Offering Size: $1,000,000 aggregate gross proceeds.
  • Note Terms:
  • Unsecured promissory notes, 12% simple annual interest, semi‑annual interest payments.
  • Principal repayment due August 11 2027; company may redeem after one year without penalty.
  • Investors:
  • Pathfinder Asset Management Ltd. – $750,000 principal amount.
  • NameSilo Technologies Corp. – $250,000 principal amount.
  • Bonus Shares:
  • 132,450 common shares issued to lenders (20% of note principal value).
  • Valued at $1.51 per share (closing price on Feb 6 2026).
  • Subject to a four‑month hold period expiring June 19 2026.
  • Use of Proceeds: Working capital, inventory acquisition, product manufacturing activities, and general corporate purposes.
  • Repayment Source: Expected cash flows from operating activities.
  • No Finders’ Fees/Commissions: None paid; lenders are arm’s‑length parties.

Notable Quotes

(No executive quotes were included in the release.)

Read the original news release →

More from Cheelcare Inc.